亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Beinaglutide for weight management in Chinese individuals with overweight or obesity: A phase 3 randomized controlled clinical study

医学 安慰剂 超重 优势比 体质指数 内科学 腰围 肥胖 减肥 置信区间 随机对照试验 不利影响 恶心 胃肠病学 替代医学 病理
作者
Kang Chen,Li Chen,Zhongyan Shan,Guixia Wang,Shen Qu,Guijun Qin,Xuefeng Yu,Weiquan Xin,Tsung‐han Hsieh,Yiming Mu
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:26 (2): 690-698 被引量:12
标识
DOI:10.1111/dom.15360
摘要

Abstract Aim To investigate the efficacy and safety of beinaglutide as an adjunct to lifestyle intervention among non‐diabetic Chinese individuals with overweight or obesity. Methods This multicentre, randomized, double‐blind, placebo‐controlled trial (ChiCTR1900023428) included 427 Chinese adults with a body mass index of 28 kg/m 2 or higher (obesity) or 24‐27.9 kg/m 2 (overweight) with weight‐related complications. Patients were randomized in a 2:1 ratio to receive 0.2 mg of beinaglutide (subcutaneous) thrice daily or placebo for 16 weeks. Co‐primary endpoints were body weight change and the proportion of patients with a weight reduction of 5% or more. Results Mean body weight change from baseline to week 16 was −6.0% and −2.4% in the beinaglutide ( n = 282) and placebo ( n = 138) groups, respectively; the mixed model repeated measures difference was −3.6% (95% confidence interval: −4.6% to −2.6%; P < .0001). At week 16, more beinaglutide‐treated patients achieved a weight reduction of 5% or more (58.2% vs. 25.4% [placebo], odds ratio: 4.4; P < .0001) and of 10% or more (21.3% vs. 5.1% [placebo], odds ratio: 5.5; P < .0001). Beinaglutide also resulted in greater waist circumference reduction (difference: −1.81 cm; P < .01). The weight regain rate 12 weeks after beinaglutide treatment was 0.78%. Nausea (transient and mild‐to‐moderate) was the most common adverse event in the beinaglutide group (49.3% vs. 7.1% [placebo]). More patients receiving beinaglutide discontinued treatment because of adverse events (5.9% vs. 0.7% [placebo]). Pancreatitis or an increased resting heart rate was not observed in the beinaglutide group. Conclusion Beinaglutide combined with lifestyle intervention resulted in significant and clinically meaningful weight reduction with good tolerance in non‐diabetic Chinese individuals with overweight or obesity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
安安爱阎魔完成签到,获得积分10
5秒前
吴玉婷发布了新的文献求助30
9秒前
绝世冰淇淋完成签到 ,获得积分10
17秒前
18秒前
chi完成签到 ,获得积分10
21秒前
我是老大应助wuran采纳,获得10
22秒前
核桃发布了新的文献求助10
22秒前
别来无恙完成签到 ,获得积分10
23秒前
23秒前
吴玉婷完成签到,获得积分20
26秒前
博慧发布了新的文献求助10
30秒前
tianya完成签到,获得积分10
30秒前
能干的台灯完成签到,获得积分10
33秒前
48秒前
Lucas应助科研通管家采纳,获得10
48秒前
ly完成签到,获得积分10
49秒前
1分钟前
在水一方应助和和和采纳,获得10
1分钟前
wuran发布了新的文献求助10
1分钟前
AiQi完成签到 ,获得积分10
1分钟前
1分钟前
博慧完成签到,获得积分10
1分钟前
wanci应助ly采纳,获得10
1分钟前
最最最发布了新的文献求助10
1分钟前
1分钟前
H_C发布了新的文献求助20
1分钟前
利好完成签到 ,获得积分10
1分钟前
1分钟前
传奇3应助简单山水采纳,获得10
1分钟前
和和和发布了新的文献求助10
1分钟前
ly发布了新的文献求助10
1分钟前
Wei完成签到 ,获得积分10
1分钟前
稻子完成签到 ,获得积分10
1分钟前
wanci应助ly采纳,获得10
1分钟前
和和和完成签到,获得积分10
2分钟前
小蘑菇应助iiii采纳,获得50
2分钟前
2分钟前
简单山水发布了新的文献求助10
2分钟前
2分钟前
灵感大王喵完成签到 ,获得积分10
2分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990015
求助须知:如何正确求助?哪些是违规求助? 3532077
关于积分的说明 11256227
捐赠科研通 3270933
什么是DOI,文献DOI怎么找? 1805139
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228